
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Princeton University has selected its Susan Dod Brown professor of mechanical and aerospace engineering Craig Arnold as its vice-dean for innovation.
Kimberly Gramm has been named the inaugural David and Marion Mussafer chief innovation and entrepreneurship officer at Tulane University.
Berkeley Frontier Fund will provide growth-stage funding to companies emerging out of the University of California campus, and has already made four investments.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Alison Campbell has been appointed CEO of the UK Government Office for Tech Transfer after eight years with Knowledge Transfer Ireland.
The small molecule drug developer, co-founded by a UCLA associate professor, has completed its series B round.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.
Yale Ventures has been launched to oversee the university’s innovation and entrepreneurship activities, including the tech transfer office.
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The metaverse technology developer has now pushed its overall funding past $750m since emerging out of Cambridge’s Department of Computer Science and Technology.
Yale Ventures has been launched to oversee the university’s innovation and entrepreneurship activities, including the tech transfer office.
MIT spinout Commonwealth Fusion Systems has raised the largest funding round yet for a nuclear fusion developer with investors including The Engine.
Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.
Diarmuid O’Brien will take over as chief executive of Cambridge Enterprise this September following the retirement of Tony Raven.